Navigation Links
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
Date:3/10/2010

ring liver transplant.

Supplemental Financial Information

The following table provides a reconciliation of Cumberland's reported (GAAP) statement of income to our adjusted (non-GAAP) statement of income for the period ended December 31, 2009. The adjusted statement includes certain items that management believes are infrequent or unusual in amount, and is provided to assist investors in evaluating Cumberland's current and future performance. The adjusted statement should not be considered a substitute for Cumberland's reported statement of income.

    
    
    Net income, as reported                                  $3,091,415
    Non-GAAP adjustments:
      Milestone expenses associated with the FDA
        approval of Caldolor                                  1,950,362
      Payroll tax expense associated with the
        exercise of nonqualified options                      1,093,464
      Tax impact of above adjustments*                       (1,211,138)
                                                             ----------
    Net income, as adjusted                                  $4,924,103
                                                             ==========
    
    Weighted-average shares outstanding - diluted            18,234,171
    
    Earnings per share - diluted (as reported)                    $0.17
    Earnings per share - diluted (as adjusted)                    $0.27
    
    
    *
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Rogne Bioscience, a privately-held biotechnology ... that preclinical and mechanism of action data will be ... Investigative Dermatology (SID) Annual Meeting being held May 6-9, ... Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... RON2315, a novel, low MW (<1700 daltons) peptide as ...
(Date:5/4/2015)... 2015  Oncobiologics, Inc., a biotherapeutics company focused ... has completed the construction of its GMP commercial ... Cranbury, New Jersey . ... designed to utilize multiple technologies that enable rapid ... the use of the latest single-use technologies, the ...
(Date:5/4/2015)... , May 4, 2015  By looking ... possible to distinguish between two very different conditions ... Theodore Henderson , MD, PhD., a ... complex cases, this study can help ... and therefore treatment options, for Post-Traumatic Stress Disorder ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... A new software technology is helping to reduce the ... identifying the sperm, eggs, resulting embryos and other materials ... cycles. Using non-invasive Radio Frequency Identification (RFID), IVF Witness(TM) ... the course of treatment. If the wrong material is ...
... 12 Nearly one in three adult Americans have triglyceride ... have low HDL "good" cholesterol levels. To help increase ... launched two Web sites: www.knowyourhdl.com and ... low HDL levels are factors that can raise the risk ...
Cached Medicine Technology:New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 3New Web Sites Educate About Triglycerides and HDL Cholesterol 2
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the ... and this beloved performer continues to roll along with no ... two legendary groups: Wings and The Beatles, has been celebrating ... on the “Out There” tour and has continually added new ...
(Date:5/4/2015)... Chicago, Ill., (PRWEB) May 04, 2015 ... the American Brain Tumor Association (ABTA) show that people ... their diagnosis and treatment options, including clinical trials, at ... of days to make difficult decisions about their course ... the launch of the first nationwide brain tumor volunteer ...
(Date:5/4/2015)... Pricing Healthcare announces it will be paying ... care at St. George Surgical Center in the ... by July 15th, 2015, and the patient must be a ... forego the filing of insurance claims). , The healthcare system ... it devastates more and more individuals and families. Rising ...
(Date:5/4/2015)... 2015 Sheltering Arms announced that it ... House. The Mother Hale Learning Center meets a tremendous ... Education. Sheltering Arms will begin operating the site immediately ... by the center. , Opened in 2006, the Mother ... to five years, many of whom come from high-need ...
(Date:5/4/2015)... New West Medicare is excited to announce they ... outpatient advanced imaging services for its members. Care to ... are provided the right test at the right time ... West Medicare’s physicians and hospitals, Care to Care will ... and provide an objective basis for informed evidence-based clinical ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... Delhi: You do not need to make sudden changes in ... the latest buzzword in the field// of health sciences, can ... the genetic makeup of your body. ,Health expert Dr. ... that now one doesn't have to go through the depression ...
... has claimed 13 lives in barely one month in Malaysia ... ,Deputy Health Director-General Ramlee Rahma said five more dengue fever ... of this year, bringing the total death toll to 13 ... has reported 1,423 suspected cases, of which 403 have been ...
... Study Center has received a $3.5 million National Institute ... ongoing, multidisciplinary research program// on autism and related developmental ... on developmental aspects and outcomes for affected patients. The ... of autism in infants at risk for the condition, ...
... University of Michigan Medical School researchers report that a single ... body weight, response to insulin// and leptin, and energy balance. ... activity in brain cells were reported in the February issue ... it’s far too early to say how this protein could ...
... powerful British MPs, members of the Committee of Public Accounts, has ... obesity//. ,Levels of obesity in children aged two to ... 1995 and 2004, according to the Health Survey for England. ... now classed as obese. ,The Public Accounts Committee report ...
... As Britons’ average waistlines expand, so does the number of ... The British Association of Aesthetic Plastic Surgeons (BAAPS) gives ... operations carried out last year, as being liposuction ... ,The most popular ‘fixes’ include areas of the ...
Cached Medicine News:Health News:A Protein in Brain Cells Controls Obesity: Research 2Health News:A Protein in Brain Cells Controls Obesity: Research 3Health News:A Protein in Brain Cells Controls Obesity: Research 4Health News:Under-Elevens Hurtle Towards Obesity, British MPs Call for Action 2Health News:Liposuction, Quick Fixes for the Obese 2
... Fully automated chemiluminescence assay for ... hormone in serum. Growth Hormone ... secreted by the anterior pituitary ... hypothalamic growth hormone releasing hormone ...
... unique DHEA-S-7kits feature a ... against the C-7 position ... with no cross-reactivity with ... RIA has been optimized ...
Inquire...
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: